Bastide le Confort Medical ( (FR:BLC) ) just unveiled an update.
Bastide le Confort Medical reported an 8.4% organic revenue growth for the first half of the 2024-2025 fiscal year, driven by a 10.2% increase in home healthcare services and a return to growth in the homecare business. The company has confirmed its revenue target of at least €560 million and aims to maintain a recurring operating margin of 8.7% by focusing on higher value-added businesses and cost control. The company plans to reduce debt by disposing of non-core assets.
More about Bastide le Confort Medical
Bastide le Confort Medical operates in the healthcare industry, focusing on home healthcare services and medical equipment. The company’s primary products and services include respiratory care, nutrition-perfusion-stomatherapy services, and homecare solutions, with a strong market presence in France, England, Canada, and Italy.
YTD Price Performance: -6.00%
Average Trading Volume: 158
Technical Sentiment Consensus Rating: Hold
Current Market Cap: €159.3M
Learn more about BLC stock on TipRanks’ Stock Analysis page.